Detalhe da pesquisa
1.
WHO 2022 classification of penile and scrotal cancers: updates and evolution.
Histopathology
; 82(4): 508-520, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36221864
2.
[Intravesical adjuvant regimen of epitubicin for intermediate risk NMIBC: Feasability study from CC-AFU vessie]. / Instauration du traitement adjuvant endovésical par épirubicine des tumeurs de vessie n'infiltrant pas le muscle : premier retour national d'expérience du CC-AFU vessie.
Prog Urol
; 32(5): 326-331, 2022 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-35151544
3.
Assessment of Xpert Bladder Cancer Monitor test performance for the detection of recurrence during non-muscle invasive bladder cancer follow-up.
World J Urol
; 39(9): 3329-3335, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33770241
4.
Dataset for the reporting of urinary tract carcinoma-biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Mod Pathol
; 33(4): 700-712, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31685965
5.
[French ccAFU guidelines - update 2020-2022: bladder cancer]. / Recommandations françaises du Comité de cancérologie de l'AFU actualisation 20202022 : tumeurs de la vessie.
Prog Urol
; 30(12S): S78-S135, 2020 Nov.
Artigo
em Francês
| MEDLINE | ID: mdl-33349431
6.
[French ccAFU guidelines - update 2020-2022: upper urinary tract urothelial carcinoma]. / Recommandations françaises du Comité de cancérologie de l'AFU - actualisation 20202022 : tumeurs de la voie excrétrice urinaire supérieure.
Prog Urol
; 30(12S): S52-S77, 2020 Nov.
Artigo
em Francês
| MEDLINE | ID: mdl-33349430
7.
ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma.
Ann Oncol
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38490358
8.
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38788900
9.
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees.
Ann Oncol
; 30(11): 1697-1727, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740927
10.
French ccAFU guidelines Update 20182020: Bladder cancer / Recommandations françaises du Comité de Cancérologie de l'AFU Actualisation 20182020 : tumeurs de la vessie
Prog Urol
; 28(S1): R48-R80, 2019 09 20.
Artigo
em Francês
| MEDLINE | ID: mdl-32093463
11.
Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive disease.
Ann Oncol
; 29(8): 1814-1821, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29945238
12.
[Prognostic value of PD-1/PD-L1 expression in upper tract urothelial carcinoma]. / Intérêt pronostique de l'expression de PD-1/PD-L1 dans les tumeurs de la voie excrétrice urinaire supérieure.
Prog Urol
; 28(16): 900-905, 2018 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-30219646
13.
[Sporadic kidney cancer of young subjects: Study of the clinical and pathological features of a bicentric cohort]. / Le cancer du rein sporadique du sujet jeune : étude des particularités cliniques et anatomopathologiques d'une cohorte bicentrique.
Prog Urol
; 28(2): 94-106, 2018 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-29170016
14.
RETRACTED: Recommandations françaises du Comité de Cancérologie de l'AFU Actualisation 20182020 : tumeurs de la voie excrétrice supérieure French ccAFU guidelines Update 20182020: Upper tract urothelial carcinoma / Recommandations françaises du Comité de Cancérologie de l'AFU Actualisation 20182020 : tumeurs de la voie excrétrice supérieure.
Prog Urol
; 28(12S): S32-S45, 2018 11.
Artigo
em Francês
| MEDLINE | ID: mdl-30318333
15.
RETRACTED: Recommandations françaises du Comité de Cancérologie de l'AFU Actualisation 20182020 : tumeurs de la vessie French ccAFU guidelines Update 20182020: Bladder cancer / Recommandations françaises du Comité de Cancérologie de l'AFU Actualisation 20182020 : tumeurs de la vessie.
Prog Urol
; 28(12S): S46-S78, 2018 11.
Artigo
em Francês
| MEDLINE | ID: mdl-30366708
16.
[ypT0N0 after neoadjuvant chemotherapy and cystectomy for muscle-invasive bladder cancer: Incidence and prognosis. A review from the Bladder group of the French Committee of Oncology]. / Pièce opératoire ypT0N0 après séquence chimiothérapie néo-adjuvante cystectomie pour TVIM : épidémiologie et impact pronostique. Une mise au point du CCAFU Vessie.
Prog Urol
; 28(12): 567-574, 2018 Oct.
Artigo
em Francês
| MEDLINE | ID: mdl-30205925
17.
[French ccAFU guidelines - Update 2018-2020: Upper tract urothelial carcinoma]. / Recommandations françaises du Comité de Cancérologie de l'AFU Actualisation 20182020 : tumeurs de la voie excrétrice supérieure.
Prog Urol
; 28 Suppl 1: R34-R47, 2018 11.
Artigo
em Francês
| MEDLINE | ID: mdl-31610873
18.
Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol
; 33(3): 244-258, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34861372
19.
[Correlation of genetic and cytogenetic alterations in pathological aggressiveness urothelial carcinoma of the bladder: Performance of BCA-1, a mini-array comparative genomic hybridisation-based test]. / Corrélation des altérations génétiques à l'agressivité anatomo-pathologique des carcinomes urothéliaux de la vessie : performance du test BCA-1.
Prog Urol
; 27(8-9): 451-457, 2017.
Artigo
em Francês
| MEDLINE | ID: mdl-28576425
20.
[Update on molecular classifications and new histological classification of bladder cancer]. / Mise au point sur les classifications moléculaires et la nouvelle classification histologique du cancer de la vessie.
Prog Urol
; 26(11-12): 600-607, 2016.
Artigo
em Francês
| MEDLINE | ID: mdl-27663304